HARRY LAY: Open Payments
NPI 1225177868 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,276 in 275 payments from 33 companies in 2025. Trend: 2023 $9,364 · 2024 $10,111 · 2025 $16,276
Consulting: $7,560Food & beverage: $5,810Speaker / faculty: $1,628Travel & lodging: $1,277
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 35 | $5,547 |
| Genentech USA, Inc. | 14 | $4,496 |
| E.R. Squibb & Sons, L.L.C. | 3 | $1,639 |
| TG Therapeutics, Inc. | 20 | $602 |
| Alexion Pharmaceuticals, Inc. | 17 | $485 |
| ABBVIE INC. | 23 | $435 |
| Celgene Corporation | 38 | $357 |
| GENZYME CORPORATION | 9 | $256 |
| UCB, Inc. | 8 | $233 |
| EMD Serono, Inc. | 12 | $227 |
Products named: KESIMPTA, Ocrevus, ZEPOSIA, BRIUMVI, ULTOMIRIS, UBRELVY, QULIPTA, Ocrevus Zunovo.
Industry payments across NC — which companies pay providers there.
